Metabolic Disorders in Chronic Obstructive Pulmonary Disease and Atherosclerosis
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Lipid Metabolism".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 3992
Special Issue Editors
Interests: COPD; respiratory diseases; atherosclerosis; lipid metabolism, lipid transport, inflammation; innate immune system
Special Issue Information
Dear Colleagues,
COPD is one of the most important problems in respiratory medicine. The disease demonstrates adverse trends in prevalence, as well as in its impact on quality of life and prognosis. In turn, the clinical significance of atherosclerosis is emphasized by the heavy medical, economic and social burden on patients, society and health care systems in many countries. It is important to note that COPD and atherosclerosis often occur in the same patient, and in most cases, it is impossible to determine exactly which one developed first. The diseases are often diagnosed in an untimely manner and mutually worsen each other's course, affecting the patient’s quality of life and prognosis. These and other data draw clinicians’ and researchers’ attention to the comorbid course of COPD and atherosclerosis.
A growing amount of evidence suggests an immune and metabolic axis that links COPD and atherosclerosis in their comorbid development and course. Metabolic dysregulation is one of the most important links in the complex chain of processes underlying the pathogenesis of both COPD and atherosclerosis. Immunometabolic switching of immune cells is an important part of inflammation in both COPD and atherosclerosis. It should be noted that the key to understanding many links in the pathogenesis of both isolated and comorbid courses of COPD and atherosclerosis is still largely unknown by clinicians and researchers.
Thus, this Special Issue focuses on original research and thorough reviews of recent advances concerning the metabolic and immune mechanisms underlying COPD and atherosclerosis. These articles can focus on various research aspects that will help to improve the understanding of the metabolic links and their pathophysiological and clinical significance.
Dr. Stanislav Kotlyarov
Dr. Xiaoyan Zhang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COPD
- atherosclerosis
- comorbidity
- metabolism
- innate immune system
- inflammation
- immunometabolism
